Welcome to the EYLEA HD® (aflibercept) Injection HCP LinkedIn page, created and sponsored by Regeneron Pharmaceuticals. The information provided on this site is intended only for healthcare professionals in the United States.
For full Prescribing Information - https://www.regeneron.com/downloads/eyleahd_fpi.pdf
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
EYLEA HD is a registered trademark of Regeneron Pharmaceuticals, Inc.
Copyright © 2024 Regeneron Pharmaceuticals, Inc. All rights reserved.
10/2024 US.EHD.24.05.0016
Contact info
https://www.regeneron.com/contact
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://EYLEAHDhcp.us
Eylea Hd® (Aflibercept) Injection Hcp Questions
Eylea Hd® (Aflibercept) Injection Hcp's website is http://EYLEAHDhcp.us
Eylea Hd® (Aflibercept) Injection Hcp's LinkedIn profile is https://www.linkedin.com/company/eylea-r-hd-aflibercept-injection
Eylea Hd® (Aflibercept) Injection Hcp's industry is
Pharmaceutical Manufacturing
Eylea Hd® (Aflibercept) Injection Hcp's top competitors are
Keytruda® (Pembrolizumab) Hcp,
Susvimo®(Ranibizumab Injection),
Regeneron,
Nova Eye Medical,
Syfovre® (Pegcetacoplan Injection) Hcp,
Vabysmoⓡ (Faricimab-Svoa),
Apellis Pharmaceuticals,
Coopervision,
Entyvio (Vedolizumab),
Retina Vitreous Associates Of Florida.
Eylea Hd® (Aflibercept) Injection Hcp's categories are Pharmaceutical Manufacturing
